Literature DB >> 31513118

Should Sagittal Spinal Alignment Targets for Adult Spinal Deformity Correction Depend on Pelvic Incidence and Age?

Themistocles S Protopsaltis1, Alexandra Soroceanu2, Jared C Tishelman1, Aaron J Buckland1, Gregory M Mundis3, Justin S Smith4, Alan Daniels5, Lawrence G Lenke6, Han Jo Kim7, Eric O Klineberg8, Christopher P Ames9, Robert A Hart10, Shay Bess11, Christopher I Shaffrey4, Frank J Schwab7, Virginie Lafage7.   

Abstract

STUDY
DESIGN: Retrospective analysis.
OBJECTIVE: Determine whether deformity corrections should vary by pelvic incidence (PI). SUMMARY OF BACKGROUND DATA: Alignment targets for deformity correction have been reported for various radiographic parameters. The T1 pelvic-angle (TPA) has gained in applications for adult spinal deformity (ASD) surgical-planning since it directly measures spinal alignment separate from pelvic- and lower-extremity compensation. Recent studies have demonstrated that ASD corrections should be age specific.
METHODS: A prospective database of consecutive ASD patients was analyzed in conjunction with a normative spine database. Clinical measures of disability included the Oswestry Disability Index (ODI) and Short Form 36 Survey (SF-36) Physical Component Score (PCS). Baseline relationships between TPA, age, PI, and ODI/SF-36 PCS scores were analyzed in the ASD and asymptomatic patients. Linear regression modeling was used to determine alignment targets based on PI and age-specific normative SF-36-PCS values.
RESULTS: Nine hundred three ASD patients (mean 53.7 yr) and 111 normative subjects (mean 50.7 yr) were included. Patients were subanalyzed by PI: low, medium, high (<40, 40-75, >75); and age: elderly (>65 yr, n = 375), middle age (45-65 yr, n = 387), and young (18-45 yr, n = 141). TPA and SRS-Schwab parameters correlated with age and PI in ASD and normative subjects (r = 0.42, P < 0.0001). ODI correlated with PCS (r = 0.71, P < 0.0001). Linear regression analysis using age-normative SF-36-PCS values demonstrated that ideal spinopelvic alignment is less strict with increasing PI and age.
CONCLUSION: Targets for ASD correction should vary by age and PI. This is demonstrated in both asymptomatic and ASD subjects. Using age-normative SF-36 PCS values, alignment targets are described for different age and PI categories. High-PI patients do not require as rigorous realignments to attain age-specific normative levels of health status. As such, sagittal spinal alignment targets increase with increasing age as well as PI. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2020        PMID: 31513118     DOI: 10.1097/BRS.0000000000003237

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Synchronous imaging of pelvic geometry and muscle morphometry: a pilot study of pelvic retroversion using upright MRI.

Authors:  Noor Shaikh; Honglin Zhang; Stephen H M Brown; Hamza Lari; Oliver Lasry; John Street; David R Wilson; Thomas Oxland
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

Review 2.  The relationship between thoracic kyphosis and age, and normative values across age groups: a systematic review of healthy adults.

Authors:  Mattia Zappalá; Stephen Lightbourne; Nicola R Heneghan
Journal:  J Orthop Surg Res       Date:  2021-07-09       Impact factor: 2.359

3.  Increasing pelvic incidence is associated with more global sagittal imbalance in ankylosing spondylitis with thoracolumbar kyphosis: an observational retrospective study of 94 cases.

Authors:  Diyu Song; Guoquan Zheng; Tianhao Wang; Dengbin Qi; Yan Wang
Journal:  BMC Musculoskelet Disord       Date:  2020-03-27       Impact factor: 2.362

4.  Differences in Demographic and Radiographic Characteristics between Patients with Visible and Invisible T1 Slopes on Lateral Cervical Radiographic Images.

Authors:  Sadayuki Ito; Hiroaki Nakashima; Akiyuki Matsumoto; Kei Ando; Masaaki Machino; Naoki Segi; Hiroyuki Tomita; Hiroyuki Koshimizu; Shiro Imagama
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.